The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2019 | Communication between CLL patients and doctors
Ben Kennedy, MB ChB, FRCP(UK), FRCPath, University Hospitals of Leicester NHS Trust, Leicester, speaks from the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He discusses the importance of open and upfront communications between doctors and patients, and gives his perspective on watch-and-wait, also called active observation, in chronic lymphocytic leukemia (CLL).
